Opus Genetics Inc. – Filings and Transcripts

NASDAQ: IRD
Share price (9/28/26): $5.05
Market cap (9/28/26): $420 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Shelf registration

Prospectus for primary offering

Shelf registration

Registration of securities for employees

Shelf registration – amended

Ownership Filter

Gagnon Robert E.

Gagnon Robert E.

Caligan Partners LP

News Filter

Investor Presentation

Announces Positive Low Dose Cohort 1 Data From Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting With Potential Phase 3 Dosing in 2027

Announces Financial Results for Second Quarter 2026 and Provides Corporate Update

Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients With Inherited Retinal Diseases

Investor Presentation

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Letter to shareholders

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC